Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▲ | Potential |
|---|---|---|---|---|---|---|---|
| Veeva Systems A | 2 | 0 | 0 | 0 | €187.85 | - | - |
| Dentsply Sirona Inc. | 10 | 0 | 0 | 0 | €26.44 | €38.55 | 45.809% |
| Pfizer Inc. | 31 | 4 | 3 | 1 | €25.83 | €41.10 | 59.129% |
| Boston Scientific | 46 | 0 | 13 | 0 | €67.50 | €72.96 | 8.084% |
| Incyte Corp. | 12 | 2 | 3 | 1 | €49.50 | €78.42 | 58.429% |
| Henry Schein Inc. | 11 | 1 | 0 | 0 | €63.96 | €79.30 | 23.985% |
| Centene Corp. | 15 | 0 | 5 | 0 | €69.30 | €82.57 | 19.149% |
| Hologic Inc. | 13 | 0 | 2 | 0 | €71.00 | €84.03 | 18.355% |
| Gilead Sciences Inc | 12 | 1 | 5 | 0 | €60.91 | €86.77 | 42.458% |
| Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €79.31 | €87.48 | 10.295% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €78.12 | €102.62 | 31.361% |
| Abbott Laboratories | 16 | 0 | 4 | 0 | €98.76 | €116.81 | 18.274% |
| Merck & Co. Inc. | 28 | 1 | 3 | 0 | €119.60 | €124.93 | 4.456% |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €121.75 | €130.00 | 6.776% |
| Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €128.20 | €133.66 | 4.260% |
| Dexcom Inc. | 18 | 0 | 3 | 0 | €118.04 | €136.82 | 15.912% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €127.10 | €144.44 | 13.646% |
| Universal Health Services B | 9 | 3 | 1 | 1 | €159.00 | €159.70 | 0.443% |
| AbbVie Inc. | 21 | 0 | 4 | 0 | €149.92 | €174.43 | 16.351% |
| Johnson & Johnson | 32 | 1 | 2 | 0 | €139.78 | €196.74 | 40.747% |
| Zoetis Inc. A | 21 | 1 | 3 | 1 | €155.90 | €200.06 | 28.324% |
| Resmed Inc. | 19 | 0 | 3 | 0 | €203.40 | €207.72 | 2.122% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €186.00 | €237.94 | 27.925% |
| Teleflex Inc. | 10 | 0 | 0 | 0 | €186.00 | €247.18 | 32.892% |
| Becton, Dickinson & Co. | 8 | 0 | 0 | 0 | €224.20 | €262.02 | 16.871% |